nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—migraine	0.624	1	CbGaD
Pranlukast—ABCC2—Verapamil—migraine	0.0755	0.303	CbGbCtD
Pranlukast—CYP2C9—Amitriptyline—migraine	0.032	0.128	CbGbCtD
Pranlukast—CYP2C9—Valproic Acid—migraine	0.0291	0.117	CbGbCtD
Pranlukast—CYP2C9—Verapamil—migraine	0.0254	0.102	CbGbCtD
Pranlukast—CYP3A4—Propranolol—migraine	0.0215	0.0863	CbGbCtD
Pranlukast—CYP3A4—Amitriptyline—migraine	0.0186	0.0746	CbGbCtD
Pranlukast—CYP3A4—Valproic Acid—migraine	0.0169	0.068	CbGbCtD
Pranlukast—CYP3A4—Topiramate—migraine	0.0153	0.0614	CbGbCtD
Pranlukast—CYP3A4—Verapamil—migraine	0.0147	0.0592	CbGbCtD
Pranlukast—MUC2—brainstem—migraine	0.00293	0.125	CbGeAlD
Pranlukast—Ospemifene—ESR1—migraine	0.00269	1	CrCbGaD
Pranlukast—NFKB1—trigeminal ganglion—migraine	0.00189	0.0808	CbGeAlD
Pranlukast—CYSLTR1—trigeminal ganglion—migraine	0.00186	0.0794	CbGeAlD
Pranlukast—MUC2—head—migraine	0.00162	0.0693	CbGeAlD
Pranlukast—MUC2—nervous system—migraine	0.00154	0.0657	CbGeAlD
Pranlukast—MUC2—central nervous system—migraine	0.00148	0.0632	CbGeAlD
Pranlukast—MUC2—cerebellum—migraine	0.00145	0.0618	CbGeAlD
Pranlukast—NFKB1—cardiovascular system—migraine	0.00137	0.0583	CbGeAlD
Pranlukast—MUC2—brain—migraine	0.00118	0.0502	CbGeAlD
Pranlukast—NFKB1—head—migraine	0.000925	0.0395	CbGeAlD
Pranlukast—CYSLTR1—head—migraine	0.000908	0.0388	CbGeAlD
Pranlukast—NFKB1—nervous system—migraine	0.000877	0.0375	CbGeAlD
Pranlukast—CYSLTR1—nervous system—migraine	0.000861	0.0368	CbGeAlD
Pranlukast—NFKB1—central nervous system—migraine	0.000844	0.0361	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—migraine	0.000829	0.0354	CbGeAlD
Pranlukast—NFKB1—cerebellum—migraine	0.000825	0.0352	CbGeAlD
Pranlukast—NFKB1—brain—migraine	0.00067	0.0286	CbGeAlD
Pranlukast—CYSLTR1—brain—migraine	0.000658	0.0281	CbGeAlD
Pranlukast—NFKB1—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.000444	0.00438	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Metabolism and Selenoproteins—FOS—migraine	0.000444	0.00438	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2B—migraine	0.000441	0.00435	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00044	0.00434	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000424	0.00418	CbGpPWpGaD
Pranlukast—NFKB1—Canonical NF-kappaB pathway—TNF—migraine	0.000423	0.00417	CbGpPWpGaD
Pranlukast—NFKB1—EBV LMP1 signaling—TNF—migraine	0.000423	0.00417	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—MTHFR—migraine	0.000423	0.00417	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000409	0.00404	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000398	0.00393	CbGpPWpGaD
Pranlukast—NFKB1—IL-4 Signaling Pathway—FOS—migraine	0.000398	0.00392	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—FOS—migraine	0.000398	0.00392	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—MTHFR—migraine	0.000396	0.0039	CbGpPWpGaD
Pranlukast—NFKB1—RANKL/RANK Signaling Pathway—FOS—migraine	0.000392	0.00386	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—TNF—migraine	0.000388	0.00382	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000382	0.00377	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000377	0.00372	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR1D—migraine	0.000373	0.00368	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CALCRL—migraine	0.000369	0.00364	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—RAMP1—migraine	0.000369	0.00364	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—ESR1—migraine	0.000367	0.00362	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—FOS—migraine	0.000365	0.0036	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000363	0.00358	CbGpPWpGaD
Pranlukast—NFKB1—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000361	0.00355	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—HTR1A—migraine	0.000359	0.00354	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000359	0.00353	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000358	0.00353	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000358	0.00353	CbGpPWpGaD
Pranlukast—CYP2C9—cardiovascular system—migraine	0.000357	0.0153	CbGeAlD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TAC1—migraine	0.000354	0.00348	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SCN1A—migraine	0.000353	0.00348	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000351	0.00346	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2B—migraine	0.000347	0.00342	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—FOS—migraine	0.000347	0.00342	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000347	0.00342	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—FOS—migraine	0.000343	0.00338	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000341	0.00336	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—ESR1—migraine	0.000339	0.00334	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR1D—migraine	0.000339	0.00334	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—MTHFR—migraine	0.000336	0.00331	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RAMP1—migraine	0.000335	0.0033	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CALCRL—migraine	0.000335	0.0033	CbGpPWpGaD
Pranlukast—NFKB1—BCR signaling pathway—FOS—migraine	0.000335	0.0033	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—FOS—migraine	0.000331	0.00326	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—CALCA—migraine	0.000326	0.00322	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HTR2A—migraine	0.000325	0.0032	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—TNF—migraine	0.000325	0.0032	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000322	0.00317	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—MTHFR—migraine	0.000322	0.00317	CbGpPWpGaD
Pranlukast—NFKB1—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—migraine	0.000317	0.00312	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2B—migraine	0.000315	0.00311	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000307	0.00303	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000306	0.00301	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—FOS—migraine	0.000303	0.00299	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SCN2A—migraine	0.0003	0.00296	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000291	0.00286	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—TNF—migraine	0.000289	0.00285	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR1B—migraine	0.000287	0.00283	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—FOS—migraine	0.000285	0.00281	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	0.000281	0.00277	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR1A—migraine	0.000277	0.00273	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000277	0.00273	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CALCRL—migraine	0.000276	0.00272	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RAMP1—migraine	0.000276	0.00272	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MEF2D—migraine	0.000275	0.00271	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000274	0.0027	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—HTR1A—migraine	0.000274	0.0027	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—TAC1—migraine	0.000272	0.00268	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—NPS—migraine	0.000272	0.00268	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—TAC1—migraine	0.000269	0.00266	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SCN1A—migraine	0.000269	0.00265	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000269	0.00265	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000268	0.00265	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—BDNF—migraine	0.000268	0.00265	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR1D—migraine	0.000268	0.00264	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2C—migraine	0.000267	0.00263	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—FOS—migraine	0.000264	0.0026	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000264	0.0026	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—FOS—migraine	0.000262	0.00258	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—TNF—migraine	0.000261	0.00258	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—EDNRA—migraine	0.00026	0.00256	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—SLC6A4—migraine	0.00026	0.00256	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.00026	0.00256	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—FOS—migraine	0.00026	0.00256	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000258	0.00254	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—MTHFR—migraine	0.000256	0.00252	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000255	0.00251	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—BDNF—migraine	0.000252	0.00248	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000251	0.00248	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CALCA—migraine	0.00025	0.00247	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2B—migraine	0.000249	0.00246	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFBR2—migraine	0.000246	0.00243	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—FOS—migraine	0.000245	0.00241	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR1D—migraine	0.000243	0.0024	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNF—migraine	0.000243	0.00239	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000243	0.00239	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—BDNF—migraine	0.00024	0.00236	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000239	0.00236	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—BDNF—migraine	0.000237	0.00234	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—TNF—migraine	0.000235	0.00231	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR7—migraine	0.000234	0.00231	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—FOS—migraine	0.000234	0.0023	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SCN2A—migraine	0.000229	0.00226	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000227	0.00224	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2B—migraine	0.000226	0.00223	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR1B—migraine	0.000226	0.00223	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—migraine	0.000224	0.00221	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—FOS—migraine	0.00022	0.00217	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR1A—migraine	0.000218	0.00215	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—migraine	0.000217	0.00214	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000215	0.00212	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—TAC1—migraine	0.000215	0.00211	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—NPS—migraine	0.000215	0.00211	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000214	0.00211	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—migraine	0.000214	0.00211	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000213	0.0021	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000213	0.0021	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—HTR2A—migraine	0.000213	0.0021	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—migraine	0.000211	0.00208	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2C—migraine	0.00021	0.00207	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MEF2D—migraine	0.000209	0.00206	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000207	0.00204	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR1B—migraine	0.000205	0.00203	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—EDNRA—migraine	0.000205	0.00202	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR1D—migraine	0.0002	0.00197	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RAMP1—migraine	0.000198	0.00195	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CALCRL—migraine	0.000198	0.00195	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR1A—migraine	0.000198	0.00195	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CALCA—migraine	0.000197	0.00194	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFBR2—migraine	0.000196	0.00193	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NPS—migraine	0.000195	0.00192	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TAC1—migraine	0.000195	0.00192	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—ESR1—migraine	0.000194	0.00191	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—BDNF—migraine	0.000192	0.00189	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2C—migraine	0.000191	0.00188	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFBR2—migraine	0.000188	0.00185	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000187	0.00184	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2B—migraine	0.000186	0.00184	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EDNRA—migraine	0.000186	0.00183	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—FOS—migraine	0.000184	0.00182	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR7—migraine	0.000184	0.00182	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000182	0.00179	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—migraine	0.000182	0.00179	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—FOS—migraine	0.000181	0.00179	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	0.000181	0.00179	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BDNF—migraine	0.000181	0.00178	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CALCA—migraine	0.000179	0.00176	CbGpPWpGaD
Pranlukast—CYP3A4—nervous system—migraine	0.000175	0.00747	CbGeAlD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—migraine	0.000174	0.00171	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—FOS—migraine	0.000171	0.00169	CbGpPWpGaD
Pranlukast—CYP3A4—central nervous system—migraine	0.000168	0.00719	CbGeAlD
Pranlukast—IL5—Signaling by GPCR—HTR7—migraine	0.000167	0.00165	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LRP1—migraine	0.000164	0.00162	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2A—migraine	0.000164	0.00162	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000163	0.00161	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR1B—migraine	0.000162	0.0016	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—FOS—migraine	0.000162	0.0016	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—HTR2A—migraine	0.000162	0.0016	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—migraine	0.000161	0.00159	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000161	0.00158	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—FOS—migraine	0.00016	0.00158	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR1A—migraine	0.000156	0.00154	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—NPS—migraine	0.000154	0.00152	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TAC1—migraine	0.000154	0.00152	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000154	0.00152	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2C—migraine	0.000151	0.00149	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.00015	0.00148	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—migraine	0.00015	0.00148	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—FOS—migraine	0.000148	0.00146	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR1B—migraine	0.000147	0.00145	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—EDNRA—migraine	0.000147	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—migraine	0.000145	0.00143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR1D—migraine	0.000144	0.00142	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000142	0.0014	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR1A—migraine	0.000142	0.0014	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CALCA—migraine	0.000141	0.00139	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NPS—migraine	0.00014	0.00138	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TAC1—migraine	0.00014	0.00138	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—migraine	0.00014	0.00138	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2C—migraine	0.000137	0.00135	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2B—migraine	0.000134	0.00132	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EDNRA—migraine	0.000133	0.00131	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR7—migraine	0.000132	0.0013	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2A—migraine	0.000129	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000128	0.00127	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CALCA—migraine	0.000128	0.00127	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOTCH4—migraine	0.000126	0.00124	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000122	0.00121	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—FOS—migraine	0.000122	0.0012	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR1B—migraine	0.000121	0.0012	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR7—migraine	0.00012	0.00118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LRP1—migraine	0.000118	0.00116	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2A—migraine	0.000117	0.00115	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR1A—migraine	0.000117	0.00115	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NPS—migraine	0.000115	0.00113	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PGR—migraine	0.000115	0.00113	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TAC1—migraine	0.000115	0.00113	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2C—migraine	0.000113	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALCRL—migraine	0.000112	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RAMP1—migraine	0.000112	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—FOS—migraine	0.000112	0.0011	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EDNRA—migraine	0.00011	0.00108	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOTCH3—migraine	0.000107	0.00105	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CALCA—migraine	0.000106	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.0001	0.000989	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR7—migraine	9.88e-05	0.000974	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2A—migraine	9.26e-05	0.000913	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—migraine	9.15e-05	0.000902	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH4—migraine	9.03e-05	0.00089	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR1B—migraine	8.71e-05	0.000859	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—migraine	8.62e-05	0.00085	CbGpPWpGaD
Pranlukast—IL5—Immune System—FOS—migraine	8.56e-05	0.000844	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFBR2—migraine	8.51e-05	0.000839	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2A—migraine	8.41e-05	0.000829	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR1A—migraine	8.39e-05	0.000827	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TAC1—migraine	8.26e-05	0.000814	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NPS—migraine	8.26e-05	0.000814	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PGR—migraine	8.26e-05	0.000814	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1D—migraine	8.14e-05	0.000802	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2C—migraine	8.1e-05	0.000798	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EDNRA—migraine	7.88e-05	0.000777	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	7.78e-05	0.000767	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH3—migraine	7.68e-05	0.000757	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CALCA—migraine	7.58e-05	0.000747	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2B—migraine	7.57e-05	0.000746	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR7—migraine	7.09e-05	0.000699	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—migraine	6.92e-05	0.000682	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LRP1—migraine	6.66e-05	0.000657	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ESR1—migraine	6.14e-05	0.000606	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFBR2—migraine	6.11e-05	0.000602	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FOS—migraine	5.98e-05	0.000589	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH4—migraine	5.11e-05	0.000504	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—migraine	4.97e-05	0.00049	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1B—migraine	4.93e-05	0.000486	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1A—migraine	4.75e-05	0.000468	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NPS—migraine	4.68e-05	0.000461	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PGR—migraine	4.68e-05	0.000461	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TAC1—migraine	4.68e-05	0.000461	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2C—migraine	4.59e-05	0.000452	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EDNRA—migraine	4.46e-05	0.00044	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ESR1—migraine	4.41e-05	0.000435	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH3—migraine	4.35e-05	0.000428	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALCA—migraine	4.29e-05	0.000423	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR7—migraine	4.02e-05	0.000396	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—migraine	3.64e-05	0.000359	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FOS—migraine	3.48e-05	0.000343	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFBR2—migraine	3.46e-05	0.000341	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNA1A—migraine	3.17e-05	0.000312	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—migraine	2.81e-05	0.000277	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ESR1—migraine	2.5e-05	0.000246	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNA1A—migraine	2.09e-05	0.000206	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—migraine	1.05e-05	0.000103	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—migraine	6.91e-06	6.81e-05	CbGpPWpGaD
